Founder and CEO, AtPoint
Dr. Rawan Al-Kharboosh is the founder and CEO of AtPoint, a biotech and life science company specialized in space-medicine and stem cell engineering for point of care applications. She believes in the possibility of patients becoming self repairing by using their own stem cells to replenish and restore cells that have undergone permanent damage. Her company aims to acquire and engineer cellular products using novel applications and devices at the point of care for same-day treatments. She received her PhD from the Mayo Clinic with dual concentrations in neuroscience and regenerative science and a master’s in tumor biology, graduating top of her class from Georgetown’s Lombardi Comprehensive Cancer Center. Dr. Al-Kharboosh has extensive expertise in stem cell engineering, FDA regulatory policies, clinical trials, and cellular manufacturing. She is a co investigator of a human clinical trial using adipose stem cells based on her thesis. Her findings are being applied in human patients bearing recurrent brain cancer in a phase I dose-escalation study at the Mayo Clinic. This investigational new drug (IND) from the FDA is based off her academic work using stem cells from adipose tissue (fat). She has further developed and optimized an FDA-approved protocol for stem cell acquisition using a table-top device for GI fistulas and knee arthritis to enhance regeneration and repair. Dr. Al-Kharboosh has also launched her stem cell products on the EXOS aerospace rocket to study the impact of microgravity on the cellular uptake of nanoparticles. Dr. Al-Kharboosh is a TEDx fellow and has authored numerous book chapters and scientific publications on brain cancer. In recognition of her work, she was invited to speak at notable conferences including the International Public Fund in partnership with UNESCO, the World Federation of Neurological Societies, the Society of Neuro oncology, and the Congress of Neurosurgery, among others.